|
Á¦À̾ØÆÄÆ®³ÊÁîÄÚ¸®¾Æ(ÁÖ) |
[¹ÙÀÌ¿À»óÀå»ç] ÀÓ»ó¿î¿µ/PV/RA
°æ±â ¼º³²½Ã ºÐ´ç±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
°æ·Â¹«°ü |
ä¿ë½Ã |
06.09 |
|
|
ÇÁ·ÎÇÚÁîÄÚ¸®¾Æ |
»óÀåÁ¦¾à»ç PV(ÁÖÀÓ~°úÂ÷Àå±Þ)
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
2³â¡è |
ä¿ë½Ã |
08.31 |
|
|
Á¦À̾ØÆÄÆ®³ÊÁîÄÚ¸®¾Æ(ÁÖ) |
[±¹³»Á¦¾à»ç] PV ÆÀ¿ø
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
3³â¡è |
ä¿ë½Ã |
04.13 |
|
|
ÇÁ·ÎÇÚÁîÄÚ¸®¾Æ |
´ëÇüÁ¦¾à»ç PV/MI(´ë¸®~°úÀå±Þ)
°æ±â ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
2³â¡è |
ä¿ë½Ã |
05.03 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
»óÀå´ë±â¾÷-PV.PMS¾÷¹«
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
PL/PV/PMS/MD |
°æ·Â¹«°ü |
ä¿ë½Ã |
12.18 |
|
|
JYpartners |
[[±Þ±¸]] PV or CRA 2³â ÀÌ»ó °æ·ÂÀÚ PV manager
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
3³â¡è |
ä¿ë½Ã |
03.11 |
|
|
JYpartners |
[[µ¶ÀÏ°è Åõ¼® Àü¹®±â¾÷]]PV manager ½Å±Ôä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
3³â¡è |
ä¿ë½Ã |
11.02 |
|
|
JYpartners |
[[µ¶ÀÏ°è Åõ¼® Àü¹®±â¾÷]]PV manager ½Å±Ôä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
2³â¡è |
ä¿ë½Ã |
12.03 |
|
|
¿ÍÀÌ¿¥Ä¿¸®¾î |
[ÄÚ½º´Ú»óÀå À¯¸Á ¹ÙÀÌ¿À ±â¾÷] ¾à¹°°¨½Ã(PV) ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
3³â¡è |
ä¿ë½Ã |
05.25 |
|
|
¸®Å©·çÆ® |
±Û·Î¹ú Á¦¾à.¹ÙÀÌ¿À»ç PV(3³âÀÌ»ó)
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
3³â¡è |
ä¿ë½Ã |
10.01 |
|
|
HRKorea |
°³¹ßº»ºÎ³» PVÆÀ : PV SOP/°¡À̵å¶óÀÎ µî °ü¸®¹®¼ Á¦/°³Á¤
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
2³â¡è |
ä¿ë½Ã |
12.22 |
|
|
Àª¾ØºñÀü |
[6°³¿ù/¿ë»ê] ¿Ü±¹°èÁ¦¾à¼ PVÆÀ »ç¹«Admin ´ëÇлý ÀÎÅÏ Ã¤
¼¿ï ¿ë»ê±¸, ¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
°æ·Â¹«°ü |
ä¿ë½Ã |
03.14 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
»óÀå ¹ÙÀÌ¿ÀÁ¦¾à»ç ÀÓ»ó PV °æ·Â ä¿ë
¼¿ï °³²±¸ | Çз¹«°ü |
PL/PV/PMS/MD |
°æ·Â¹«°ü |
ä¿ë½Ã |
04.27 |
|
|
HRKorea |
Pharmacovigilance Specialist
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
3³â¡è |
ä¿ë½Ã |
05.18 |
|
|
(ÁÖ)ÇÇÇÃÄɾî½áÄ¡ |
Pharmacist -¿Ü±¹°èÁ¦¾à»ç
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
6³â¡è |
ä¿ë½Ã |
07.13 |
|